Skip to contentSkip to Braille Studio

Library / Laws / 119th Congress / Senate Bills / S. 2513

S. 2513

To amend the Federal Food, Drug, and Cosmetic Act with respect to transparency and reporting regarding over-the-counter drug monograph activities, and for other purposes.

Print stageDateSize⠃
Introduced in Senate2025-07-295.4K⠃⠗⠋